Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
复制标题
英夫利昔单抗治疗活动性银屑病关节炎患者的两年疗效和安全性：英夫利昔单抗跨国银屑病关节炎对照试验 (IMPACT) 的结果。
DOI：
--
复制
发表时间：
2008
期刊：
影响因子：
--
通讯作者：
Manger,Ber
中科院分区：
文献类型：
--
作者：
Antoni,ChristianE;Kavanaugh,Arthur;vanderHeijde,Désirée;Beutler,Anna;Keenan,Gregory;Zhou,Bei;Kirkham,Bruce;Tutuncu,Zuhre;Burmester,GerdR;Schneider,Udo;Furst,DanielE;Molitor,Jerry;Keystone,Edward;Gladman,DafnaD;Manger,Ber
